TTUHSC researcher receives patent for schistosomiasis vaccine - Lubbock AJ
Lubbock AJ - Dr. Afzal Siddiqui received patent for a vaccine he created through TTUHSC research to treat schistosomiasis.
The disease is more prevalent in countries outside the continental United States, potentially putting 800 million people at risk.
“This vaccine is a chance to improve the lives of 200 million people,” said Dr. Michael Conn, vice president of research for TTUHSC, in reference to the number of people affected by the disease. “This kind of opportunity doesn’t come along often.”
Related Stories
TTUHSC Names New Regional Dean for the School of Nursing
Louise Rice, DNP, RN, has been named regional dean of the TTUHSC School of Nursing on the Amarillo campus.
A Call for Change: Addressing the Invisible Workload of School-Based SLPs
Tobias Kroll, Ph.D., CCC-SLP, an Associate Professor in the Department of Speech, Language and Hearing Sciences, discusses the workloads and expectations of school-based SLPs.
Noise-Induced Hearing Loss in Rural Adolescents
Leigh Ann Reel, Au.D., Ph.D., CCC-A, discussed the causes and prevention strategies for noise-induced hearing loss, particularly for adolescents in rural areas.
Recent Stories
TTUHSC MAT Students Receive Coveted NFL Internships
Jill Manners, ScD, LAT, ATC, PT, NREMT, COMT, FNAP, is giving us a closer look into the NFL internship opportunities that some of the MAT students are experiencing over the summer.
Collaborative Team Earns Five-Year Renewal Grant from NINDS to Continue Stroke Research
Due to this high level of productivity and potential to create new medications for stroke injury, NINDS recently awarded a new $3 million competitive renewal that extends the grant for an additional five years.
Keep Pushing: PA Alumni Gives Back
Jemimah Omavuezi, DMS, MPAS, PA-C, used her own story as inspiration to create the Omavuezi Scholarship for others.